Literature DB >> 24113860

Current use of chelation in American health care.

Paul M Wax1.   

Abstract

The National Center for Health Statistics estimates that more than 100,000 Americans receive chelation each year, although far fewer than 1 % of these cases are managed by medical toxicologists. Unfortunately, fatalities have been reported after inappropriate chelation use. There are currently 11 FDA-approved chelators available by prescription although chelation products may also be obtained through compounding pharmacies and directly over the internet. Promotion of chelation training is prominent on some alternative and complementary medicine websites.

Mesh:

Substances:

Year:  2013        PMID: 24113860      PMCID: PMC3846961          DOI: 10.1007/s13181-013-0347-2

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  11 in total

1.  British anti-lewisite (BAL).

Authors:  R A PETERS; L A STOCKEN; R H S THOMPSON
Journal:  Nature       Date:  1945       Impact factor: 49.962

Review 2.  The role of chelation in the treatment of arsenic and mercury poisoning.

Authors:  Michael J Kosnett
Journal:  J Med Toxicol       Date:  2013-12

3.  Role of chelation in the treatment of lead poisoning: discussion of the Treatment of Lead-Exposed Children Trial (TLC).

Authors:  Charles A McKay
Journal:  J Med Toxicol       Date:  2013-12

4.  Regulating compounding pharmacies after NECC.

Authors:  Kevin Outterson
Journal:  N Engl J Med       Date:  2012-11-07       Impact factor: 91.245

Review 5.  The scientific basis for chelation: animal studies and lead chelation.

Authors:  Donald Smith; Barbara J Strupp
Journal:  J Med Toxicol       Date:  2013-12

Review 6.  Mercury exposure: evaluation and intervention the inappropriate use of chelating agents in the diagnosis and treatment of putative mercury poisoning.

Authors:  John F Risher; Sherlita N Amler
Journal:  Neurotoxicology       Date:  2005-08       Impact factor: 4.294

7.  The Toxicology Investigators Consortium Case Registry--the 2011 experience.

Authors:  Timothy J Wiegand; Paul M Wax; Tayler Schwartz; Yaron Finkelstein; Rachel Gorodetsky; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2012-12

8.  Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.

Authors:  A A A Van der Linde; S Pillen; G P J M Gerrits; J N Bouwes Bavinck
Journal:  Clin Toxicol (Phila)       Date:  2008-06       Impact factor: 4.467

9.  Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-03-03       Impact factor: 17.586

10.  Complementary and alternative medicine use among adults and children: United States, 2007.

Authors:  Patricia M Barnes; Barbara Bloom; Richard L Nahin
Journal:  Natl Health Stat Report       Date:  2008-12-10
View more
  8 in total

1.  Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.

Authors:  Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

Review 2.  Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.

Authors:  Johant Lakey-Beitia; Andrea M Burillo; Giovanni La Penna; Muralidhar L Hegde; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 3.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

4.  Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms.

Authors:  Chunfang Xie; Julien Slagboom; Laura-Oana Albulescu; Govert W Somsen; Freek J Vonk; Nicholas R Casewell; Jeroen Kool
Journal:  Acta Pharm Sin B       Date:  2020-09-15       Impact factor: 11.413

Review 5.  Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.

Authors:  Filippo Ravalli; Xavier Vela Parada; Francisco Ujueta; Rachel Pinotti; Kevin J Anstrom; Gervasio A Lamas; Ana Navas-Acien
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

6.  TPEN exerts selective anti-leukemic efficacy in ex vivo drug-resistant childhood acute leukemia.

Authors:  Miguel Mendivil-Perez; Carlos Velez-Pardo; Gloria E David-Yepes; Javier E Fox; Marlene Jimenez-Del-Rio
Journal:  Biometals       Date:  2020-10-24       Impact factor: 2.949

7.  CORR Insights®: Is NS-EDTA Effective in Clearing Bacteria From Infected Wounds in a Rat Model?

Authors:  Stephen Alan Kennedy
Journal:  Clin Orthop Relat Res       Date:  2018-05       Impact factor: 4.176

8.  Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics.

Authors:  Ian Moore F Gilpin; Martin Ullrich; Thomas Wünsche; Kristof Zarschler; Ondřej Lebeda; Jens Pietzsch; Hans-Jürgen Pietzsch; Martin Walther
Journal:  ChemMedChem       Date:  2021-06-16       Impact factor: 3.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.